In 2014, after years of positive growth, we launched MAPS Public Benefit Corporation (MAPS PBC)—our sister in psychedelic research. The goal of MAPS PBC is to catalyze healing and well-being through psychedelic drug development, therapist training programs, and, ultimately, the sales of prescription psychedelics.